Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus topical lidocaine for post-extubation airway complications
IRCT20260209068811N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Primary composite endpoint. Started May 2026; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on IRCT20260209068811N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260209068811N1.